Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Pathologic stages I and II Hodgkin's disease, 1968-1975: relapses and results of retreatment

Journal Article · · Cancer; (United States)
; ;
Sixty-seven previously untreated patients with Hodgkin's disease, pathologic stages I and II, seen during a 7-year period were evaluated with respect to initial staging and treatment, as well as relapse and retreatment results. The initial treatment consisted of radiation therapy (RT) to an involved field (IF) or an extended field (EF) for patients with stages IA and IIA, or RT and, in recent cases, combination chemotherapy (cyclophosphamide, Oncovin, procarbazine, and prednisone (COPP)) for patients with stages IB and IIB. Nineteen of the 67 patients relapsed (28%), including 11 of 56 patients with stages IA and IIA (20%) and 8 of 11 patients with stages IB and IIB (73%). Seventeen of the 19 relapses occurred within 24 months after completion of the initial therapy (89%). The relapse-free survival at 5 years was 75% for the A patients and 25% for the B patients. The actuarial survival of stage IA and IIA patients at 5 years was 91%; there was no significant difference between patients treated initially with either IF or EF. The actuarial survival at 5 years for the patients with stages IB and IIB was 88%, as most responded to a second program of induction therapy. No correlation could be found between the pattern of relapse and the initial pathologic stage or the mode of treatment.
Research Organization:
Univ. of Chicago, IL
OSTI ID:
5332590
Journal Information:
Cancer; (United States), Journal Name: Cancer; (United States) Vol. 44:1; ISSN CANCA
Country of Publication:
United States
Language:
English

Similar Records

Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types. Results of sequential staging procedures, response to therapy, and survival of 100 patients
Journal Article · Sat Jul 01 00:00:00 EDT 1978 · Cancer; (United States) · OSTI ID:6724704
Combination chemotherapy of lymphomas other than Hodgkin's disease. [Vincristine, prednisone, cyclophosphamide, procarbazine]
Journal Article · Thu Oct 31 23:00:00 EST 1974 · Ann. Intern. Med.; (United States) · OSTI ID:5276418
Supradiaphragmatic Hodgkin's disease: significance of large mediastinal masses
Journal Article · Tue Jul 01 00:00:00 EDT 1980 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6854561

Related Subjects

550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
CHEMOTHERAPY
DISEASES
HODGKINS DISEASE
IMMUNE REACTIONS
LYMPHOMAS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PATHOLOGY
PATIENTS
RADIATION EFFECTS
RADIOLOGY
RADIOTHERAPY
SARCOMAS
SIDE EFFECTS
THERAPY